PROK ProKidney Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: PROK

Price (delayed)

$2.34

Market cap

$677.84M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.59

Enterprise value

$470M

Highlights
ProKidney's equity has increased by 26% YoY and by 11% from the previous quarter
PROK's quick ratio is up by 23% QoQ and by 15% YoY
ProKidney's debt has soared by 127% YoY and by 12% from the previous quarter
The EPS has declined by 11% year-on-year and by 3.5% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Peers: OLMA OMER OMGA ONCT

Key stats

What are the main financial stats of PROK
Market
Shares outstanding
289.68M
Market cap
$677.84M
Enterprise value
$470M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$34.93M
EBITDA
-$30.4M
Free cash flow
-$153.21M
Per share
EPS
-$0.59
Free cash flow per share
-$2.02
Book value per share
-$4.2
Revenue per share
$0
TBVPS
$6.58
Balance sheet
Total assets
$499.16M
Total liabilities
$26.8M
Debt
$6.67M
Equity
-$972.37M
Working capital
$429.67M
Liquidity
Debt to equity
-0.01
Current ratio
21.87
Quick ratio
20.96
Net debt/EBITDA
6.84
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-8.8%
Return on equity
N/A
Return on invested capital
-12.2%
Return on capital employed
-7.3%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PROK stock price

How has the ProKidney stock price performed over time
Intraday
-2.09%
1 week
-2.09%
1 month
-2.5%
1 year
-63.49%
YTD
31.46%
QTD
-4.88%

Financial performance

How have ProKidney's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$153.96M
Net income
-$38.68M
Gross margin
N/A
Net margin
N/A
The net income has declined by 10% since the previous quarter and by 4% year-on-year
ProKidney's operating income has decreased by 5% YoY and by 2.1% from the previous quarter

Growth

What is ProKidney's growth rate over time

Valuation

What is ProKidney stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has declined by 11% year-on-year and by 3.5% since the previous quarter
ProKidney's equity has increased by 26% YoY and by 11% from the previous quarter

Efficiency

How efficient is ProKidney business performance
The return on invested capital has surged by 60% year-on-year but it has declined by 9% since the previous quarter
The return on assets has declined by 21% year-on-year and by 9% since the previous quarter

Dividends

What is PROK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PROK.

Financial health

How did ProKidney financials performed over time
ProKidney's total assets has increased by 29% QoQ and by 3.1% YoY
The current ratio is up by 24% since the previous quarter and by 15% year-on-year
ProKidney's debt is 101% more than its equity
ProKidney's debt has soared by 127% YoY and by 12% from the previous quarter
ProKidney's equity has increased by 26% YoY and by 11% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.